Folic acid-modified bovine serum albumin nanoparticles with doxorubicin and chlorin e6 for effective combinational chemo-photodynamic therapy
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 117, 111343
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
This publication has 44 references indexed in Scilit:
- A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug deliveryBiomaterials, 2013
- Beyond DNA Repair: Additional Functions of PARP-1 in CancerFrontiers in Oncology, 2013
- Photosensitizer-Conjugated Human Serum Albumin Nanoparticles for Effective Photodynamic TherapyTheranostics, 2011
- Synthesis of a novel magnetic drug delivery system composed of doxorubicin-conjugated Fe3O4 nanoparticle cores and a PEG-functionalized porous silica shellChemical Communications, 2010
- Understanding biophysicochemical interactions at the nano–bio interfaceNature Materials, 2009
- The biology of ovarian cancer: new opportunities for translationNature Reviews Cancer, 2009
- Effects of nanomaterial physicochemical properties on in vivo toxicityAdvanced Drug Delivery Reviews, 2009
- Drug delivery and nanoparticles: Applications and hazardsInternational Journal of Nanomedicine, 2008
- Thermo- and pH-responsive polymers in drug delivery☆Advanced Drug Delivery Reviews, 2006
- Ovarian cancerEuropean Journal of Cancer, 2002